the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Trump: No more debates with Kamala Harris

WASHINGTON: Republican nominee Donald Trump said on Thursday he would not participate in another presidential debate against Kamala Harris ahead of the Nov. 5 election, after several polls showed his Democratic rival won their debate earlier this week.

“THERE WILL BE NO THIRD DEBATE!” the former president wrote on social media site Truth Social. Trump had participated in a debate against President Joe Biden in June before his debate against Harris on Tuesday.

Although Trump touted his performance on Tuesday against Harris, six Republican donors and three Trump advisers who spoke to Reuters earlier this week said they thought Harris had won the debate largely because Trump was unable to stay on message.

The debate attracted 67.1 million television viewers, according to Nielsen data.

Harris, speaking at a rally shortly after Trump’s post went live, said: “I believe we owe it to the voters to have another debate.”

While Trump said in his post that polls showed he won the debate, several surveys showed that respondents thought Harris did better.

Among voters who said they had heard at least something about Tuesday’s debate, 53% said Harris won and 24% said Trump won, according to a Reuters/Ipsos poll released on Thursday.

The poll showed that 54% of registered voters believed that the single debate between Trump and Harris was enough, while 46% had wanted a second debate.

A majority of debate watchers said Harris outperformed Trump, according to a CNN flash poll released shortly after the debate. YouGov showed 54% of those surveyed said Harris won while 31% said Trump was the victor.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings